Clinical Trial Update: A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the safety and tolerability of brivaracetam in children and adolescents with seizures; the study status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Briviact (brivaracetam)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Epilepsy | Phase 3 | Status: RECRUITING